Keros Therapeutics (KROS) Revenue (2019 - 2025)
Keros Therapeutics (KROS) reported Revenue of $577000.0 for Q4 2025, up 213.58% on a YoY basis from $184002.5 in Q4 2024, and down 95.95% quarter-over-quarter from $14.3 million in Q3 2025.
Keros Therapeutics (KROS) Revenue (2019 - 2025) Analysis & Trends
Keros Therapeutics has reported Revenue for 6 years, with the latest figure at $577000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 213.58% year-over-year to $577000.0; the trailing twelve-month figure through Dec 2025 stood at $244.3 million (up 203644.17% YoY), and the FY2025 full-year result was $244.1 million, changed N/A from the prior year.
- Revenue for Q4 2025 stood at $577000.0, down from $14.3 million in the prior quarter.
- The five-year high for Revenue was $211.2 million in Q1 2025, with the low at -$508000.0 in Q4 2024.
- Historically, Revenue has averaged $25.5 million across 5 years, with a median of $577000.0 in 2025.
- The largest YoY upside for Revenue was 4750.0% in 2024 against a maximum downside of 455.24% in 2024.
- Keros Therapeutics' Revenue stood at $17.9 million in 2021, then grew by 0.56% to $18.0 million in 2022, then slumped by 99.21% to $143000.0 in 2023, then sank by 455.24% to -$508000.0 in 2024, then jumped by 213.58% to $577000.0 in 2025.
- The last three Revenue figures came in at $577000.0 (Q4 2025), $14.3 million (Q3 2025), and $18.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Keros Therapeutics | 399.01 Mn | 111.61 Mn | - | 577,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 18.17 Mn |
| Mar 31, 2025 | 211.25 Mn |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 17.90 Mn |
| Jun 30, 2021 | 100,000.00 |
| Dec 31, 2019 | 2.50 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 2.50 Mn |
| Mar 31, 2019 | 2.50 Mn |